4.5 Article

Effect of Abrupt Discontinuation of Antidepressants in Critically Ill Hospitalized Adults

Related references

Note: Only part of the references are listed.
Review Psychiatry

Withdrawal Symptoms after Selective Serotonin Reuptake Inhibitor Discontinuation: A Systematic Review

Giovanni A. Fava et al.

PSYCHOTHERAPY AND PSYCHOSOMATICS (2015)

Article Psychology, Clinical

Meta-Analysis of Selective Serotonin Reuptake Inhibitor-Associated QTc Prolongation

Scott R. Beach et al.

JOURNAL OF CLINICAL PSYCHIATRY (2014)

Letter Clinical Neurology

Long-Term Duloxetine Withdrawal Syndrome and Management in a Depressed Patient

Yi-Cheng Hou

JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES (2014)

Review Pharmacology & Pharmacy

A Comparison of the Risk of QT Prolongation Among SSRIs

Kylee A. Funk et al.

ANNALS OF PHARMACOTHERAPY (2013)

Article Clinical Neurology

Hallucination induced by paroxetine discontinuation in patients with major depressive disorders

Norio Yasui-Furukori et al.

PSYCHIATRY AND CLINICAL NEUROSCIENCES (2011)

Review Psychiatry

Gender differences in antidepressant drug response

Robert Keers et al.

INTERNATIONAL REVIEW OF PSYCHIATRY (2010)

Article Psychiatry

Symptoms of delusion: the effects of discontinuation of low-dose venlafaxine

M. Koga et al.

ACTA PSYCHIATRICA SCANDINAVICA (2009)

Article Clinical Neurology

Body weight as a predictor of antidepressant efficacy in the GENDEP project

Rudolf Uher et al.

JOURNAL OF AFFECTIVE DISORDERS (2009)

Article Clinical Neurology

Delirium following abrupt discontinuation of fluoxetine

Diana Blum et al.

CLINICAL NEUROLOGY AND NEUROSURGERY (2008)

Letter Pharmacology & Pharmacy

Nocturnal enuresis after paroxetine abrupt discontinuation - A case report

Giovanni Polimeni et al.

JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2008)

Article Clinical Neurology

BMI, sex, and antidepressant response

Arif Khan et al.

JOURNAL OF AFFECTIVE DISORDERS (2007)

Article Pharmacology & Pharmacy

Discontinuation symptoms in users of selective serotonin reuptake inhibitors in clinical practice: tapering versus abrupt discontinuation

ECG van Geffen et al.

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2005)

Article Clinical Neurology

Influence of P-glycoprotein inhibition on the distribution of the tricyclic antidepressant nortriptyline over the blood-brain barrier

TB Ejsing et al.

HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2005)

Review Clinical Neurology

Gender differences in treatment response to sertraline versus imipramine in patients with nonmelancholic depressive disorders

E Baca et al.

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2004)

Article Pharmacology & Pharmacy

Discontinuation symptoms: comparison of brief interruption in fluoxetine and paroxetine treatment

R Judge et al.

INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2002)

Review Pharmacology & Pharmacy

Pharmacokinetic and pharmacodynamic considerations when treating patients with sepsis and septic shock

P De Paepe et al.

CLINICAL PHARMACOKINETICS (2002)

Article Clinical Neurology

Restlessness related to SSRI withdrawal

S Hirose

PSYCHIATRY AND CLINICAL NEUROSCIENCES (2001)

Review Public, Environmental & Occupational Health

Antidepressant discontinuation syndromes - Clinical relevance, prevention and management

PM Haddad

DRUG SAFETY (2001)

Article Psychiatry

Gender differences in treatment response to sertraline versus imipramine in chronic depression

SG Kornstein et al.

AMERICAN JOURNAL OF PSYCHIATRY (2000)